DUBLIN--(BUSINESS WIRE)--Feb 21, 2025--
The "South Korea Flow Cytometry Market: Analysis and Forecast, 2024-2033" report has been added to ResearchAndMarkets.com's offering.
Flow cytometry has emerged as a transformative technology in South Korea, driven by advancements in research and industrial applications. This versatile technology enables high-throughput analysis of single cells, offering applications ranging from clinical diagnostics to industrial biotechnology. South Korea's commitment to innovation and R&D investments has catalyzed the adoption of flow cytometry, with significant contributions from key players like Becton, Dickinson and Company, Danaher Corporation (Beckman Coulter), and Thermo Fisher Scientific Inc.
Despite challenges such as high costs and technological complexity, the growth trajectory of flow cytometry in South Korea is promising, supported by government initiatives and increasing healthcare and biotech investments.
The South Korean flow cytometry market was valued at $82.12 million in 2024 and is projected to reach $244.49 million by 2033, growing at a CAGR of 12.89% during the forecast period (2024-2033). Investments in flow cytometry in the country saw a significant year-on-year increase of 23.23% from $431.3 million in 2020 to $531.5 million in 2021. This upward trend reflects the growing importance of this technology across clinical, research, and industrial domains.
Recent Developments:
Industrial-Scale Developments
- January 2024: SML Meditree partnered with Sengenics to distribute its immune proteomics platform, KREX, in South Korea.
- February 2022: IDEXX Laboratories launched the Procyte One analyzer in South Korea, leveraging advanced flow cytometry laser technology.
Research-Scale Developments
- August 2023: Seoul St. Mary's Hospital researchers received recognition for their work on MRD monitoring using multi-parametric flow cytometry.
- January 2023: Expansion of Eunpyeong St. Mary's Hospital to enhance its analytical capabilities, including additional flow cytometers.
These developments highlight the expanding role of flow cytometry in both research and clinical settings within South Korea.
Market Demand Drivers and Limitations
The following are the demand drivers for South Korea flow cytometry market:
- Increasing Healthcare Investments and Biotechnology and Pharmaceutical Manufacturing in South Korea
- Increasing Research and Development Expenditure in the Country
The market is expected to face some limitations due to the following challenges:
The South Korean flow cytometry market is poised for substantial growth, underpinned by increasing investments in healthcare and biotechnology, advancements in technology, and expanding applications in diagnostics and research. Despite challenges such as high costs and reliance on imports, opportunities in automation, AI integration, and emerging clinical applications position South Korea as a key player in the global flow cytometry landscape. Strategic collaborations and adherence to stringent regulatory standards will further bolster the market's trajectory over the next decade.
Competitive Strategy:
A detailed competitive benchmarking of the players operating in the South Korea flow cytometry market has been done to help the reader understand how players stack against each other, presenting a clear market landscape. Additionally, comprehensive competitive strategies such as partnerships, agreements, and collaborations will aid the reader in understanding the untapped revenue pockets in the market.
Key Players in the South Korea Flow Cytometry Market profiled in the report include:
- Agilent Technologies, Inc.
- Becton, Dickinson and Company
- Bio-Rad Laboratories, Inc.
- Cytek Biosciences, Inc.
- Danaher Corporation (Beckman Coulter)
- II-VI Incorporated
- Sony Group Corporation (Sony Biotechnology)
- Sysmex Corporation
- Thermo Fisher Scientific Inc.
- Miltenyi Biotec
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 108 |
| Forecast Period | 2024 - 2033 |
| Estimated Market Value (USD) in 2024 | $82.12 Million |
| Forecasted Market Value (USD) by 2033 | $244.49 Million |
| Compound Annual Growth Rate | 12.8% |
| Regions Covered | South Korea |
Key Topics Covered:
1 Market Overview
1.1 Introduction
1.2 Market Footprint
1.2.1 Major Flow Cytometry Systems
1.2.2 Market Penetration of Flow Cytometry
1.2.3 Recent Developments
1.2.4 SWOT Analysis
1.3 Regulatory Compliance
1.4 Technology Landscape
2 Market Dynamics
2.1 Impact Analysis
2.2 Market Drivers
2.2.1 Increasing Healthcare Investments and Biotechnology and Pharmaceutical Manufacturing in South Korea
2.2.2 Increasing Research and Development Expenditure in the Country
2.3 Market Restraints
2.3.1 High Cost of Acquisition
2.4 Market Opportunities
2.4.1 Increasing Use of Automation in Flow Cytometry Laboratories
3 Product Mapping
3.1 Instrument Product Mapping Analysis
3.2 Consumable Product Mapping Analysis
3.3 Imagin System and Software Product Mapping Analysis
4 Competitive Insights
4.1 Product Launches
4.2 Expansion
4.3 Increasing Awareness
4.4 Market Share Analysis (by Company)
4.5 Growth-Share Matrix
5 South Korea Flow Cytometry Market, by Product
5.1 Overview
5.2 Instruments
5.2.1 Key Players
5.2.2 Platforms
5.2.3 Replaceable Components and Accessories
5.3 Reagents and Consumables
5.3.1 Key Players
5.3.2 Antibodies
5.3.3 Fluorescent Dye
5.3.4 Beads
5.3.5 Others
5.4 Imaging Systems and Software
6 South Korea Flow Cytometry Market, by Method
6.1 Overview
6.2 Bead-based Flow Cytometry
6.3 Cell-based Flow Cytometry
7 South Korea Flow Cytometry Market, by Application
7.1 Overview
7.2 Clinical Applications
7.2.1 Cancer
7.2.2 Hematology
7.2.3 Autoimmune Diseases
7.2.4 Organ Transplantation
7.2.5 Others
7.3 Research Applications
7.3.1 Drug Discovery
7.3.2 Stem Cell Research
7.3.3 In-Vitro Toxicology Testing
7.3.4 Biomarker Detection
7.3.5 Cell Apoptosis
7.3.6 Cell Cycle Analysis
7.3.7 Cell Viability
7.3.8 Others
7.4 Industrial Applications
7.4.1 Food and Beverages
7.4.2 Water Treatment
7.4.3 Microbiology Testing
7.4.4 Cosmetics and Personal Care Industry
7.4.5 Agriculture and Fermentation Industry
7.4.6 Other Industries
8 South Korea Flow Cytometry Market, by End Users
8.1 Overview
8.2 Academic and Research Institutes
8.3 Hospitals and Clinical Testing Laboratories
8.4 Pharmaceutical and Biotechnology Companies
8.5 Industrial Companies
8.6 Others
9 Company Profiles
- Agilent Technologies, Inc.
- Becton, Dickinson and Company
- Bio-Rad Laboratories, Inc.
- Cytek Biosciences, Inc.
- Danaher Corporation (Beckman Coulter)
- II-VI Incorporated
- Sony Group Corporation (Sony Biotechnology)
- Sysmex Corporation
- Thermo Fisher Scientific Inc.
- Miltenyi Biotec
For more information about this report visit https://www.researchandmarkets.com/r/2417tn
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
View source version on businesswire.com:https://www.businesswire.com/news/home/20250221108883/en/
CONTACT: ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
KEYWORD: ASIA PACIFIC SOUTH KOREA
